Cargando…

Optimal method for metabolic tumour volume assessment of cervical cancers with inter-observer agreement on [18F]-fluoro-deoxy-glucose positron emission tomography with computed tomography

PURPOSE: Cervical cancer metabolic tumour volume (MTV) derived from [18F]-FDG PET/CT has a role in prognostication and therapy planning. There is no standard method of outlining MTV on [18F]-FDG PET/CT. The aim of this study was to assess the optimal method to outline primary cervical tumours on [18...

Descripción completa

Detalles Bibliográficos
Autores principales: Arshad, Mubarik A., Gitau, Samuel, Tam, Henry, Park, Won-Ho E., Patel, Neva H., Rockall, Andrea, Aboagye, Eric O., Bharwani, Nishat, Barwick, Tara D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113292/
https://www.ncbi.nlm.nih.gov/pubmed/33313962
http://dx.doi.org/10.1007/s00259-020-05136-8
_version_ 1783690830646607872
author Arshad, Mubarik A.
Gitau, Samuel
Tam, Henry
Park, Won-Ho E.
Patel, Neva H.
Rockall, Andrea
Aboagye, Eric O.
Bharwani, Nishat
Barwick, Tara D.
author_facet Arshad, Mubarik A.
Gitau, Samuel
Tam, Henry
Park, Won-Ho E.
Patel, Neva H.
Rockall, Andrea
Aboagye, Eric O.
Bharwani, Nishat
Barwick, Tara D.
author_sort Arshad, Mubarik A.
collection PubMed
description PURPOSE: Cervical cancer metabolic tumour volume (MTV) derived from [18F]-FDG PET/CT has a role in prognostication and therapy planning. There is no standard method of outlining MTV on [18F]-FDG PET/CT. The aim of this study was to assess the optimal method to outline primary cervical tumours on [18F]-FDG PET/CT using MRI-derived tumour volumes as the reference standard. METHODS: 81 consecutive cervical cancer patients with pre-treatment staging MRI and [18F]-FDG PET/CT imaging were included. MRI volumes were compared with different PET segmentation methods. Method 1 measured MTVs at different SUV(max) thresholds ranging from 20 to 60% (MTV(20)-MTV(60)) with bladder masking and manual adjustment when required. Method 2 created an isocontour around the tumour prior to different SUV(max) thresholds being applied. Method 3 used an automated gradient method. Inter-observer agreement of MTV, following manual adjustment when required, was recorded. RESULTS: For method 1, the MTV(25) and MTV(30) were closest to the MRI volumes for both readers (mean percentage change from MRI volume of 2.9% and 13.4% for MTV(25) and − 13.1% and − 2.0% for MTV(30) for readers 1 and 2). 70% of lesions required manual adjustment at MTV(25) compared with 45% at MTV(30). There was excellent inter-observer agreement between MTV(30) to MTV(60) (ICC ranged from 0.898–0.976 with narrow 95% confidence intervals (CIs)) and moderate agreement at lower thresholds (ICC estimates of 0.534 and 0.617, respectively for the MTV(20) and MTV(25) with wide 95% CIs). Bladder masking was performed in 86% of cases overall. For method 2, excellent correlation was demonstrated at MTV(25) and MTV(30) (mean % change from MRI volume of −3.9% and − 8.6% for MTV(25) and − 16.9% and 19% for MTV(30) for readers 1 and 2, respectively). This method also demonstrated excellent ICC across all thresholds with no manual adjustment. Method 3 demonstrated excellent ICC of 0.96 (95% CI 0.94–0.97) but had a mean percentage difference from the MRI volume of − 19.1 and − 18.2% for readers 1 and 2, respectively. 21% required manual adjustment for both readers. CONCLUSION: MTV(30) provides the optimal correlation with MRI volume taking into consideration the excellent inter-reader agreement and less requirement for manual adjustment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-020-05136-8.
format Online
Article
Text
id pubmed-8113292
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-81132922021-05-13 Optimal method for metabolic tumour volume assessment of cervical cancers with inter-observer agreement on [18F]-fluoro-deoxy-glucose positron emission tomography with computed tomography Arshad, Mubarik A. Gitau, Samuel Tam, Henry Park, Won-Ho E. Patel, Neva H. Rockall, Andrea Aboagye, Eric O. Bharwani, Nishat Barwick, Tara D. Eur J Nucl Med Mol Imaging Original Article PURPOSE: Cervical cancer metabolic tumour volume (MTV) derived from [18F]-FDG PET/CT has a role in prognostication and therapy planning. There is no standard method of outlining MTV on [18F]-FDG PET/CT. The aim of this study was to assess the optimal method to outline primary cervical tumours on [18F]-FDG PET/CT using MRI-derived tumour volumes as the reference standard. METHODS: 81 consecutive cervical cancer patients with pre-treatment staging MRI and [18F]-FDG PET/CT imaging were included. MRI volumes were compared with different PET segmentation methods. Method 1 measured MTVs at different SUV(max) thresholds ranging from 20 to 60% (MTV(20)-MTV(60)) with bladder masking and manual adjustment when required. Method 2 created an isocontour around the tumour prior to different SUV(max) thresholds being applied. Method 3 used an automated gradient method. Inter-observer agreement of MTV, following manual adjustment when required, was recorded. RESULTS: For method 1, the MTV(25) and MTV(30) were closest to the MRI volumes for both readers (mean percentage change from MRI volume of 2.9% and 13.4% for MTV(25) and − 13.1% and − 2.0% for MTV(30) for readers 1 and 2). 70% of lesions required manual adjustment at MTV(25) compared with 45% at MTV(30). There was excellent inter-observer agreement between MTV(30) to MTV(60) (ICC ranged from 0.898–0.976 with narrow 95% confidence intervals (CIs)) and moderate agreement at lower thresholds (ICC estimates of 0.534 and 0.617, respectively for the MTV(20) and MTV(25) with wide 95% CIs). Bladder masking was performed in 86% of cases overall. For method 2, excellent correlation was demonstrated at MTV(25) and MTV(30) (mean % change from MRI volume of −3.9% and − 8.6% for MTV(25) and − 16.9% and 19% for MTV(30) for readers 1 and 2, respectively). This method also demonstrated excellent ICC across all thresholds with no manual adjustment. Method 3 demonstrated excellent ICC of 0.96 (95% CI 0.94–0.97) but had a mean percentage difference from the MRI volume of − 19.1 and − 18.2% for readers 1 and 2, respectively. 21% required manual adjustment for both readers. CONCLUSION: MTV(30) provides the optimal correlation with MRI volume taking into consideration the excellent inter-reader agreement and less requirement for manual adjustment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-020-05136-8. Springer Berlin Heidelberg 2020-12-11 2021 /pmc/articles/PMC8113292/ /pubmed/33313962 http://dx.doi.org/10.1007/s00259-020-05136-8 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Arshad, Mubarik A.
Gitau, Samuel
Tam, Henry
Park, Won-Ho E.
Patel, Neva H.
Rockall, Andrea
Aboagye, Eric O.
Bharwani, Nishat
Barwick, Tara D.
Optimal method for metabolic tumour volume assessment of cervical cancers with inter-observer agreement on [18F]-fluoro-deoxy-glucose positron emission tomography with computed tomography
title Optimal method for metabolic tumour volume assessment of cervical cancers with inter-observer agreement on [18F]-fluoro-deoxy-glucose positron emission tomography with computed tomography
title_full Optimal method for metabolic tumour volume assessment of cervical cancers with inter-observer agreement on [18F]-fluoro-deoxy-glucose positron emission tomography with computed tomography
title_fullStr Optimal method for metabolic tumour volume assessment of cervical cancers with inter-observer agreement on [18F]-fluoro-deoxy-glucose positron emission tomography with computed tomography
title_full_unstemmed Optimal method for metabolic tumour volume assessment of cervical cancers with inter-observer agreement on [18F]-fluoro-deoxy-glucose positron emission tomography with computed tomography
title_short Optimal method for metabolic tumour volume assessment of cervical cancers with inter-observer agreement on [18F]-fluoro-deoxy-glucose positron emission tomography with computed tomography
title_sort optimal method for metabolic tumour volume assessment of cervical cancers with inter-observer agreement on [18f]-fluoro-deoxy-glucose positron emission tomography with computed tomography
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113292/
https://www.ncbi.nlm.nih.gov/pubmed/33313962
http://dx.doi.org/10.1007/s00259-020-05136-8
work_keys_str_mv AT arshadmubarika optimalmethodformetabolictumourvolumeassessmentofcervicalcancerswithinterobserveragreementon18ffluorodeoxyglucosepositronemissiontomographywithcomputedtomography
AT gitausamuel optimalmethodformetabolictumourvolumeassessmentofcervicalcancerswithinterobserveragreementon18ffluorodeoxyglucosepositronemissiontomographywithcomputedtomography
AT tamhenry optimalmethodformetabolictumourvolumeassessmentofcervicalcancerswithinterobserveragreementon18ffluorodeoxyglucosepositronemissiontomographywithcomputedtomography
AT parkwonhoe optimalmethodformetabolictumourvolumeassessmentofcervicalcancerswithinterobserveragreementon18ffluorodeoxyglucosepositronemissiontomographywithcomputedtomography
AT patelnevah optimalmethodformetabolictumourvolumeassessmentofcervicalcancerswithinterobserveragreementon18ffluorodeoxyglucosepositronemissiontomographywithcomputedtomography
AT rockallandrea optimalmethodformetabolictumourvolumeassessmentofcervicalcancerswithinterobserveragreementon18ffluorodeoxyglucosepositronemissiontomographywithcomputedtomography
AT aboagyeerico optimalmethodformetabolictumourvolumeassessmentofcervicalcancerswithinterobserveragreementon18ffluorodeoxyglucosepositronemissiontomographywithcomputedtomography
AT bharwaninishat optimalmethodformetabolictumourvolumeassessmentofcervicalcancerswithinterobserveragreementon18ffluorodeoxyglucosepositronemissiontomographywithcomputedtomography
AT barwicktarad optimalmethodformetabolictumourvolumeassessmentofcervicalcancerswithinterobserveragreementon18ffluorodeoxyglucosepositronemissiontomographywithcomputedtomography